Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours Β· Estimated delivery Aug 23 - Aug 28
Jazmin Aguilera: So today were talking all about GLP-1s and their potential to help curb addiction
[Krimberg & Wittandt Biochem Z 251 231 1932, Strack et al
Key Highlights FDA approval and US launch of generic Saxenda (liraglutide injection) First-ever generic GLP-1 indicated for weight loss in the US market Teva's fifth first-to-market generic launch this year Indicated for adults with obesity or overweight and pediatric patients (12-17 years) with obesity Incidence and Prevalence Global Prevalence of Obesity: Latest Estimates The prevalence of obesity is increasing globally, with a particularly significant rise observed over the past decades in Western and Westernizing countries where rates have more than doubled in the last decade
The low and uneven rates of coverage for Medicaid beneficiaries lead to substantial gaps in accessing eating disorder treatment
US$ 24.81
US$ 27.56
US$ 29.02
US$ 27.36
US$ 20.02
US$ 25.98
US$ 22.34
US$ 23.72
US$ 23.50
US$ 26.61
